Teprotumumab is effective for TED but carries risk of serious side effects

Teprotumumab has proven efficacy in patients with thyroid eye disease (TED) and potential in treating compressive optic neuropathy, but adverse events have been noted.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553